ReoPro GPIIb/IIIa inhibitor data

CNTO published results from its CAPTURE study in The Lancet, testing the ability of ReoPro to

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE